Stem Cell Cartilage Regeneration Market to Reflect Steady Growth Rate by 2026

Stem Cell Cartilage Regeneration Market
Size, Share, Trend, Outlook, Future Growth
Analysis And Synthesis 2018 - 2026
Stem cells therapy are emerging as an important therapeutic option in the field of cartilage regeneration.
Rapid development of stem cell-based therapy for cartilage regeneration in the recent past has been
witnessed across the world. Stem cells are mainly classified in three kinds of cells: hematopoietic stem
cell, mesenchymal stem cells, and pluripotent stem cells.
The global stem cell cartilage regeneration market size was valued at US$ 254.4 million in 2017, and is
expected to witness a CAGR of 8.9% over the forecast period (2018 – 2026).
Request Free Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/2448
Increasing Adoption of Minimally Invasive Surgery Procedures is expected to Drive Growth of Stem Cell
Cartilage Regeneration Market
Stem cell therapy for knees, minimally invasive procedure, has the potential to decrease inflammation,
halt progression of arthritic damage, repair joint cartilage, and delay or avoid knee replacement surgery.
Injection of progenitor cells, especially mesenchymal stem cells (MSCs), has been found to be an
effective and better solution for repairing degenerative cartilage compared to implantation of
differentiated cells such as articular cartilage.
In addition to this, other potential benefits such as lower risk and shorter duration of minimally invasive
surgery procedures are expected to fuel demand for stem cell therapy for cartilage regeneration during
the forecast period. For instance, according to NCBI 2016 report, a minimally invasive procedure to
harvest stem cells from both fat and bone marrow and inject the concentrated cells under image
guidance can be performed in 2-3 hours.
Stem Cell Cartilage Regeneration Market - Regional Insights
On the basis of region, the global stem cell cartilage regeneration market is segmented into North
America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to be
the most conducive region for growth of the stem cell cartilage regeneration market over the forecast
period, due to high presence of key players in the region. Key players such as Vericel Corporation,
Osiris Therapeutics, among others are focusing on various growth strategies such as gaining regulatory
product approvals and launching innovative stem cell based cartilage regeneration products and
technologies in the market.
Report includes chapters which deeply display the following deliverable about industry :
• Stem Cell Cartilage Regeneration Market Research Objective and Assumption
• Stem Cell Cartilage Regeneration Market Purview - Report Description, Executive Summary,
and Coherent Opportunity Map (COM)
• Stem Cell Cartilage Regeneration Market Dynamics, Regulations, and Trends Analysis - Market
Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system
Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Stem Cell Cartilage Regeneration Market, By Regions
• Stem Cell Cartilage Regeneration Market Competition by Manufacturers including Production,
Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Stem Cell Cartilage Regeneration Market Manufacturers Profiles/Analysis including Company
Basic Information, Manufacturing Base and Its Competitors.
• Stem Cell Cartilage Regeneration Market Manufacturing Cost Analysis including Key Raw
Materials and Key Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Stem Cell Cartilage Regeneration Market Forecast including Production, Consumption, Import
and Export Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Stem Cell Cartilage Regeneration Market - Competitive Landscape
Key players operating in the global stem cell cartilage regeneration market include Theracell Advanced
Biotechnology Ltd., Orthocell Ltd., Xintela AB, CellGenix GmbH, Merck KGaA, Osiris Therapeutics, Inc.,
BioTissue SA, and Vericel Corporation.
Detailed Segmentation:
Global Stem Cell Cartilage Regeneration Market, By Stem Cell Type:
•
Hematopoietic Stem Cells (HSCs)
•
Pluripotent Stem Cells (iPSC/ESCs)
•
Mesenchymal Stem Cells (MSCs)
Global Stem Cell Cartilage Regeneration Market, By Treatment:
•
Microfracture
•
Osteochondral Transplant
•
Autologous Chondrocyte Implantation
•
Stem Cell Injections
Get Full Access of This Business Report: https://www.coherentmarketinsights.com/market-insight/
stem-cell-cartilage-regeneration-market-2448
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

Global stem cell cartilage regeneration market size was valued at US$ 254.4 million in 2017, and is expected to witness a CAGR of 8.9% over 2018 – 2026.